Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome/interstitial cystitis, bladder capacity and potassium sensitivity

Lukas K. Daha, Claus Riedl, Dara Lazar, R. Simak, Heinz Pflüger

Scandinavian Journal of Urology and Nephrology · 2008 · 22 citations · 20 references

Abstract

These data demonstrate that in patients who respond symptomatically to intravesical GAG substitution therapy, cystometric bladder capacity is increased, whereas non-responders experience a decrease in bladder capacity.

References

20